JNBA Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$953 Sell
159
-17
-10% -$128 ﹤0.01% 791
2025
Q4
$1.26K Sell
176
-20
-10% -$158 ﹤0.01% 724
2025
Q3
$2.09K Hold
196
﹤0.01% 601
2025
Q2
$1.9K Hold
196
﹤0.01% 603
2025
Q1
$2.92K Hold
196
﹤0.01% 576
2024
Q4
$2.92K Hold
196
﹤0.01% 572
2024
Q3
$3.75K Hold
196
﹤0.01% 568
2024
Q2
$4.06K Hold
196
﹤0.01% 539
2024
Q1
$3.69K Sell
196
-12
-6% -$206 ﹤0.01% 562
2023
Q4
$3K Sell
208
-10
-5% -$136 ﹤0.01% 583
2023
Q3
$3.79K Hold
218
﹤0.01% 574
2023
Q2
$4.54K Sell
218
-8
-4% -$174 ﹤0.01% 545
2023
Q1
$5.32K Buy
226
+7
+3% +$188 ﹤0.01% 540
2022
Q4
$6.12K Sell
219
-107
-33% -$2.74K ﹤0.01% 497
2022
Q3
$8K Sell
326
-136
-29% -$4.11K ﹤0.01% 489
2022
Q2
$16K Sell
462
-14
-3% -$490 ﹤0.01% 432
2022
Q1
$17K Sell
476
-69
-13% -$2.36K ﹤0.01% 433
2021
Q4
$17K Sell
545
-17
-3% -$554 ﹤0.01% 446
2021
Q3
$18K Sell
562
-145
-21% -$4.64K ﹤0.01% 434
2021
Q2
$21K Buy
+707
New +$23.3K ﹤0.01% 399

Other funds holding OGN

JNBA Financial Advisors's OGN Position: Q1 2026 in Review

JNBA Financial Advisors reduced its Organon & Co (OGN) stake by 9.7% in Q1 2026, selling an estimated $128 and leaving 159 shares worth $953. The position accounts for ﹤0.01% of the portfolio, ranked #791.

JNBA Financial Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $21K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • JNBA Financial Advisors held 159 shares of Organon & Co worth $953 as of Q1 2026.
  • JNBA Financial Advisors sold 17 Organon & Co shares in Q1 2026, an estimated $128.
  • Organon & Co made up ﹤0.01% of JNBA Financial Advisors's portfolio in Q1 2026, its #791 holding.
  • JNBA Financial Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • JNBA Financial Advisors's Organon & Co position peaked at $21K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on JNBA Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.